PROVIDER PROFILE · NPI 1508853672
Martin SlavinMD
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,479
Unique beneficiaries
—
Total services
177,899
Distinct HCPCS
16
Medicare payment
$169K
Peer benchmark
Total Medicare services vs. 7,864 Internal Medicine providers in NY — top quintile (cohort median 552).
PRESCRIBING · PART D · 2024
Total Rx claims
5,660
Beneficiaries
—
Total drug cost
$729K
Distinct drugs
113
Brand share
22.8%
Top prescribed drugs
Atorvastatin Calcium380 claims
Amlodipine Besylate304 claims
Losartan Potassium267 claims
Metoprolol Succinate202 claims
Rosuvastatin Calcium196 claims
QUALITY · MIPS · 2024
Final MIPS score
22.9
Quality
0.0
Cost
76.3
Improvement activities
0.0
Promoting interop.
0.0
Payment adjustment
-6.25%
Individual
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$3K
Payment records
146
By payment type
Food and Beverage$3K
Top paying entities
Food and Beverage$3K
REFERRAL NETWORK
Where Martin Slavin's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Lenco Diagnostic Laboratories,inc. Clinical Laboratory · Brooklyn, NY | 102 | 267 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE